Last reviewed · How we verify
Epsilon Aminocaproic Acid — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Epsilon Aminocaproic Acid (Epsilon Aminocaproic Acid) — Wake Forest University Health Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Epsilon Aminocaproic Acid TARGET | Epsilon Aminocaproic Acid | Wake Forest University Health Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Epsilon Aminocaproic Acid CI watch — RSS
- Epsilon Aminocaproic Acid CI watch — Atom
- Epsilon Aminocaproic Acid CI watch — JSON
- Epsilon Aminocaproic Acid alone — RSS
Cite this brief
Drug Landscape (2026). Epsilon Aminocaproic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/epsilon-aminocaproic-acid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab